MC
RGEN icon

Moors & Cabot’s Repligen RGEN Stock Holding History

Moors & Cabot’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-10,300
Closed -$206K – 536
2014
Q4 		$206K Buy
10,300
+300
+3% +$6.71K 0.03% 450
2014
Q3 		$200K Sell
10,000
-400
-4% -$8.42K 0.03% 483
2014
Q2 		$235K Buy
+10,400
New +$185K 0.04% 438

Other funds holding RGEN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Moors & Cabot's RGEN Position: Q1 2015 in Review

Moors & Cabot sold out of Repligen (RGEN) in Q1 2015, closing a stake of 10,300 shares — an estimated $206K sold.

Moors & Cabot first reported a position in RGEN in Q2 2014 and held it in 3 quarters. The position peaked at $235K in Q2 2014. 168 funds tracked by Wall St. Rank hold RGEN as of Q1 2015.

  • Moors & Cabot reported no remaining Repligen position as of Q1 2015 after selling out during the quarter.
  • Moors & Cabot sold 10,300 Repligen shares in Q1 2015, an estimated $206K.
  • Moors & Cabot first reported a position in Repligen in Q2 2014 and held it in 3 quarters.
  • Moors & Cabot's Repligen position peaked at $235K in Q2 2014.
  • 168 funds tracked by Wall St. Rank held Repligen as of Q1 2015.

Based on Moors & Cabot's 13F filing for Q1 2015, filed 14 May 2015.